Drug Profile
Research programme: Hib-meningococcal vaccine groups A C Y and W-153 polysaccharide conjugate - Chongqing Zhifei Biological Products
Alternative Names: ACYW135-Hib polysaccharide conjugate vaccineLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chongqing Zhifei Biological Products
- Class Haemophilus vaccines; Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Haemophilus infections; Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Haemophilus-infections in China (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Meningococcal-group-A-infections in China (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Meningococcal-group-C-infections in China (Parenteral, Injection)